Abcam

Abcam Limited
Formerly
  • Abcam Limited (1998–2005)
  • Abcam plc (2005–2023)
TypeSubsidiary
Industry
Founded1998 (1998)
Founders
HeadquartersCambridge Biomedical Campus, ,
UK
Key peopleMarkus Lusser (president)
Products
RevenueIncrease £361.7 million (2022)
Decrease £(10.1) million (2022)
Decrease £(8.5) million (2022)
Total assetsIncrease £1,057 million (2022)
Total equityIncrease £726.9 million (2022)
Number of employees
1,760 (2022)
Parent
Website

Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023.